News

Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has ...
Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
The Arctic is now warming faster than most other regions in the world, potentially disrupting the key current that ...
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies ...
Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has successfully closed a public offering, raising approximately $23 million in ...
There are no signs of tropical development across the Atlantic, Caribbean and Gulf for the next week, at least. Even the long ...
Arctic ocean is warming at record pace, threatening collapse of AMOC and heightening risk of severe coastal flooding in ...
High pressure off in the Atlantic is bringing a quiet start to the workweek with sunny skies and lower humidity. A trough to our south will continue to move north the ...
Two years after Sam Altman pitched Congress on AI guardrails, he's back in Washington with a new message: To beat China, ...